<DOC>
	<DOC>NCT01151020</DOC>
	<brief_summary>The Zenith® TX2® Low Profile TAA Endovascular Graft study is a clinical trial approved by US FDA to evaluate the safety and effectiveness of the Zenith® TX2® Low Profile TAA Endovascular Graft indicated for the treatment of patients with aneurysms/ulcers of the descending thoracic aorta having vessel structure suitable for repair.</brief_summary>
	<brief_title>TX2® Low Profile TAA Endovascular Graft</brief_title>
	<detailed_description />
	<mesh_term>Aneurysm</mesh_term>
	<mesh_term>Vascular Diseases</mesh_term>
	<mesh_term>Aortic Aneurysm</mesh_term>
	<criteria>Descending thoracic aneurysm with diameter ≥ 5.0 cm Descending thoracic aneurysm with a history of growth ≥ 0.5 cm per year Descending thoracic degenerative or atherosclerotic ulcer ≥ 10 mm in depth and 20 mm in diameter Less than 18 years of age Life expectancy less than 2 years Pregnant or breastfeeding or planning on becoming pregnant within 60 months Unwilling to comply with the followup schedule Inability or refusal to give informed consent Less than 30 days beyond primary endpoint for other investigative drug or device study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Aortic Aneurysm</keyword>
	<keyword>Aneurysm</keyword>
	<keyword>Vascular Prosthesis</keyword>
	<keyword>Vascular Disease</keyword>
	<keyword>Blood Vessel Prosthesis Implantation</keyword>
</DOC>